Use of Novel Combination Therapies in the Treatment of Advanced HR+/HER2- Breast Cancer.

This article reviews current endocrine treatment strategies and recent and ongoing studies of combination therapies in metastatic hormone receptor-positive, HER2-negative breast cancer. PMID: 30538108 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30538108?dopt=Abstract

Source: Journal of the National Comprehensive Cancer Network : JNCCN - December 13, 2018 Category: Cancer & Oncology Tags: J Natl Compr Canc Netw Source Type: research